BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ollila HM. Narcolepsy type 1: what have we learned from genetics? Sleep 2020;43:zsaa099. [PMID: 32442260 DOI: 10.1093/sleep/zsaa099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mainieri G, Montini A, Nicotera A, Di Rosa G, Provini F, Loddo G. The Genetics of Sleep Disorders in Children: A Narrative Review. Brain Sci 2021;11:1259. [PMID: 34679324 DOI: 10.3390/brainsci11101259] [Reference Citation Analysis]
2 Sarfraz N, Okuampa D, Hansen H, Alvarez M, Cornett EM, Kakazu J, Kaye AM, Kaye AD. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy. Health Psychology Research 2022;10. [DOI: 10.52965/001c.34222] [Reference Citation Analysis]
3 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]